Deep Vein Thrombosis (DVT) Prevention in Total Hip Replacement: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)

This study is currently recruiting participants.
Information provided by Medical Compression Systems

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Venous Thrombosis
			Pulmonary Embolism
2		Additional conditions recognized in this trial
			Embolism
			Thrombosis
3		More general conditions related to this trial
			Cardiovascular Diseases
			Embolism and Thrombosis
			Lung Diseases
			Respiratory Tract Diseases
			Vascular Diseases
4		Interventions listed in this trial
			ActiveCare+SFT
5		Additional drug interventions recognized in this trial
			Heparin, Low-Molecular-Weight
6		More general drug interventions related to this trial
			Anticoagulants
			Cardiovascular Agents
			Fibrin Modulating Agents
			Fibrinolytic Agents
			Hematologic Agents
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Therapeutic Uses
7		Sponsors listed in this trial
			Medical Compression Systems